Please select the option that best describes you:
How would you decide the duration of ovarian suppression in premenopausal females with early stage ER+ breast cancer?
Do you utilize ovarian suppression for two years (per Astraa trial) vs 5 years (SOFT/TEXT) or until menopausal?